Evelo Biosciences, Inc. Profile Avatar - Palmy Investing

Evelo Biosciences, Inc.

Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase…

Biotechnology
US, Cambridge [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of EVLO's Analysis
CIK: 1694665 CUSIP: 299734103 ISIN: US2997342025 LEI: - UEI: -
Secondary Listings
EVLO has no secondary listings inside our databases.